Saturday, October 31, 2026

Atlanticus Holdings Corporation And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

ViaNews Editorial Team

August 19, 2024

Atlanticus Holdings Corporation  And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

(VIANEWS) - Atlanticus Holdings Corporation (ATLC), PriceSmart (PSMT), Independent Bank Corporation (IBCP) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Atlanticus Holdings Corporation (ATLC)

11% sales growth and 18.86% return on equity

Atlanticus Holdings Corporation provides credit and related financial services and products to customers the United States. It operates in two segments, Credit as a Service, and Auto Finance. The Credit as a Service segment originates a range of consumer loan products, such as private label and general purpose credit cards originated by lenders through various channels, including retail and healthcare, direct mail solicitation, digital marketing, and partnerships with third parties; and offers credit to their customers for the purchase of various goods and services, including consumer electronics, furniture, elective medical procedures, healthcare, educational services, and home-improvements by partnering with retailers and service providers. In addition, it offers loan servicing, such as risk management and customer service outsourcing for third parties; and engages in testing and investment activities in consumer finance technology platforms. The Auto Finance segment purchases and/or services loans secured by automobiles from or for a pre-qualified network of independent automotive dealers and automotive finance companies in the buy-here, pay-here, and used car business. This segment also provides floor plan financing and installment lending products. Further, the company invests in and services portfolios of credit card receivables. Atlanticus Holdings Corporation was founded in 1996 and is headquartered in Atlanta, Georgia.

Earnings Per Share

As for profitability, Atlanticus Holdings Corporation has a trailing twelve months EPS of $4.21.

PE Ratio

Atlanticus Holdings Corporation has a trailing twelve months price to earnings ratio of 7.24. Meaning, the purchaser of the share is investing $7.24 for every dollar of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 18.86%.

Yearly Top and Bottom Value

Atlanticus Holdings Corporation's stock is valued at $30.47 at 20:22 EST, way below its 52-week high of $39.53 and way higher than its 52-week low of $23.10.

Sales Growth

Atlanticus Holdings Corporation's sales growth is 11% for the present quarter and 11% for the next.

2. PriceSmart (PSMT)

8.8% sales growth and 11.46% return on equity

PriceSmart, Inc. owns and operates U.S. style membership shopping warehouse clubs in the United States, Central America, the Caribbean, and Colombia. Its warehouse clubs sell brand name and private label consumer products, essential goods, fresh produce, prepared foods, and fresh-baked goods, as well as provides services, such as optical, tire center, and other ancillary services. The company also operates Click & Go, an e-commerce platform for online ordering, curbside pickup, and delivery services. As of March 29, 2022, it operated 49 warehouse clubs in 12 countries and one U.S. territory. PriceSmart, Inc. was incorporated in 1994 and is headquartered in San Diego, California.

Earnings Per Share

As for profitability, PriceSmart has a trailing twelve months EPS of $4.11.

PE Ratio

PriceSmart has a trailing twelve months price to earnings ratio of 20.84. Meaning, the purchaser of the share is investing $20.84 for every dollar of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 11.46%.

3. Independent Bank Corporation (IBCP)

7% sales growth and 16.34% return on equity

Independent Bank Corporation operates as the bank holding company for Independent Bank that provides commercial banking services to individuals and businesses in rural and suburban communities across Lower Michigan. It offers checking and savings accounts, commercial lending, direct and indirect consumer financing, mortgage lending, and safe deposit box services. The company also provides title insurance services and investment services. Independent Bank Corporation was founded in 1864 and is based in Grand Rapids, Michigan.

Earnings Per Share

As for profitability, Independent Bank Corporation has a trailing twelve months EPS of $3.12.

PE Ratio

Independent Bank Corporation has a trailing twelve months price to earnings ratio of 10.18. Meaning, the purchaser of the share is investing $10.18 for every dollar of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 16.34%.

Volume

Today's last reported volume for Independent Bank Corporation is 2049 which is 98.18% below its average volume of 112611.

Yearly Top and Bottom Value

Independent Bank Corporation's stock is valued at $31.76 at 20:22 EST, way under its 52-week high of $35.97 and way above its 52-week low of $16.90.

4. STAAR Surgical Company (STAA)

5.4% sales growth and 4.36% return on equity

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers preloaded silicone intraocular lenses, as well as preloaded injectors for use in cataract surgery. In addition, the company sells injector parts, and other related instruments and devices. STAAR Surgical Company markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, and Italy. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.

Earnings Per Share

As for profitability, STAAR Surgical Company has a trailing twelve months EPS of $0.33.

PE Ratio

STAAR Surgical Company has a trailing twelve months price to earnings ratio of 114.88. Meaning, the purchaser of the share is investing $114.88 for every dollar of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 4.36%.

Growth Estimates Quarters

The company's growth estimates for the ongoing quarter and the next is a negative 40% and a negative 46.2%, respectively.

Revenue Growth

Year-on-year quarterly revenue growth grew by 7.3%, now sitting on 332.94M for the twelve trailing months.

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,525 source documents archived
Query this data → isubstrate.com